Eric Chang

Reproductive tract immune cells from pregnant women or those using depot medroxyprogesterone acetate show no excess susceptibility to HIV-1: results of an ex vivo fusion assay.

R. Greenblatt, K. Smith-McCune, J. Hilton, 2020, Contraception.

Effects of the levonorgestrel-containing intrauterine device, copper intrauterine device, and levonorgestrel-containing oral contraceptive on susceptibility of immune cells from cervix, endometrium and blood to HIV-1 fusion measured ex vivo

R. Greenblatt, K. Smith-McCune, J. Hilton, 2019, PloS one.

A post-market, randomized, controlled, prospective study evaluating intrathecal pain medication versus conventional medical management in the non-cancer, refractory, chronic pain population (PROSPER)

T. Deer, J. Pope, Samuel Grodofsky, 2022, Expert review of medical devices.